All News

The approval of Amgen’s trastuzumab-anns, the fifth biosimilar to Herceptin, marks the twentieth biosimilar approved by the FDA.

Investigators aim to develop cellular models to mimic the biological processes responsible for the onset of multiple sclerosis.

Slow walking speed associated with higher risk of poor outcomes for older patients with blood cancers.

Top news of the day from across the health care landscape.

A new study finds duel benefit of the varicella vaccine

Genentech is seeking approval for rituximab (Rituxan) with glucocorticoids for pediatric patients with granulomatosis with polyangiitis and microscopic polyangiitis.

Patients with hemophilia A across all age groups reported stabilization or improvement of quality of life and high treatment satisfaction.

The trial analyzed the impact of vitamin K intake on patients who were taking warfarin to decrease the risk of blood clots.

Top news of the day from across the health care landscape.

In the statement, USPSTF officials noted that people who take PrEP should continue to use condoms and practice other behaviors to reduce their risk of other sexually transmitted infections.

Pembrolizumab is now indicated for use as a first-line monotherapy treatment for metastatic or unresectable recurrent head and neck squamous cell carcinoma.

An unhealthy microbiome caused by chronic antibiotic treatment could result in long-term inflammation within the tissue and tumor environment.

Top news of the day from across the health care landscape.

The Neostigmine Methylsulfate Injection is the first manufacturer-prepared, ready-to-administer prefilled syringe on the market.